Radhakrishnan Pillai
- Dermatology top 1%
- Acne and Rosacea Treatments and Effects 15
- Dermatology and Skin Diseases 13
- Skin Protection and Aging 7
- Cell Biology top 2%
- Plant Pathogens and Fungal Diseases 11
- Epidemiology top 5%
- Nail Diseases and Treatments 19
- Fungal Infections and Studies 9
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis 17
-
- Antifungal resistance and susceptibility 7
- Co-authors
- Yoshiyuki TatsumiHisato SendaDavid M. PariserJason T. OlinBoni E. ElewskiMark LebwohlRichard PollakEric Guenin
- Cited by
- DermatologyCell BiologyEpidemiology
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Journal of the American Academy of Dermatology (5 papers)Regulatory Toxicology and Pharmacology (1 paper)
- Partner nations
- United StatesJapanCanada
In The Last Decade
Radhakrishnan Pillai
56 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 74
- Dermatology 398
- Cell Biology 505
- Epidemiology 593
- Immunology 224
- Biological Psychiatry 20
Countries citing papers authored by Radhakrishnan Pillai
This map shows the geographic impact of Radhakrishnan Pillai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radhakrishnan Pillai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radhakrishnan Pillai more than expected).
Fields of papers citing papers by Radhakrishnan Pillai
This network shows the impact of papers produced by Radhakrishnan Pillai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radhakrishnan Pillai. The network helps show where Radhakrishnan Pillai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Radhakrishnan Pillai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 25 | |
| 3 | 2020 | 1 | |
| 4 | 2020 | 9 | |
| 5 | 2020 | 11 | |
| 6 | A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris | 2019 | 20 |
| 7 | Assessing the Synergistic Effect of a Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion in Moderate-to-Severe Plaque Psoriasis | 2019 | 3 |
| 8 | Efficacy of a Once-Daily Fixed Combination Halobetasol (0.01%) and Tazarotene (0.045%) Lotion in the Treatment of Localized Moderate-to-Severe Plaque Psoriasis | 2019 | 3 |
| 9 | 2019 | 30 | |
| 10 | Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials. | 2018 | 4 |
| 11 | Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque Psoriasis | 2018 | 3 |
| 12 | Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination. | 2018 | 3 |
| 13 | 2018 | 32 | |
| 14 | A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis. | 2017 | 19 |
| 15 | 2017 | 124 | |
| 16 | 2014 | 1 | |
| 17 | 2014 | 8 | |
| 18 | 2012 | 167 | |
| 19 | The position not the presence of the halogen in corticosteroids influences potency and side effects. | 2006 | 29 |
| 20 | 2001 | 13 |
About Radhakrishnan Pillai
Radhakrishnan Pillai is a scholar working on Dermatology, Cell Biology and Immunology, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nail Diseases and Treatments (19 papers), Psoriasis: Treatment and Pathogenesis (17 papers), Acne and Rosacea Treatments and Effects (15 papers), Dermatology and Skin Diseases (13 papers), Plant Pathogens and Fungal Diseases (11 papers), Fungal Infections and Studies (9 papers), Antifungal resistance and susceptibility (7 papers) and Skin Protection and Aging (7 papers). The work is most often cited by research in Dermatology (398 citations), Cell Biology (505 citations) and Epidemiology (593 citations). Radhakrishnan Pillai has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Yoshiyuki Tatsumi, Hisato Senda, David M. Pariser, Jason T. Olin, Boni E. Elewski, Mark Lebwohl, Richard Pollak, Eric Guenin, Kathleen Smith and Robert J. Israel. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of the American Academy of Dermatology and Regulatory Toxicology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.